Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market
Holding ARQT?
Track your performance easily

Arcutis Biotherapeutics (ARQT) Financial Statements

716 Followers

Arcutis Biotherapeutics Financial Overview

Arcutis Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-2.183; its P/E ratio is -4.59; Arcutis Biotherapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 30.86M$ 49.57M$ 13.53M$ 38.11M$ 5.19M
Gross Profit$ 27.39M$ 46.31M$ 10.50M$ 38.11M$ 4.77M
EBIT$ -52.33M$ -27.58M$ -58.50M$ -31.82M$ -62.09M
EBITDA$ -50.13M$ -27.22M$ -58.11M$ -32.87M$ -63.44M
Net Income Common Stockholders$ -52.33M$ -35.38M$ -66.28M$ -42.40M$ -70.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 362.44M$ 403.87M$ 271.86M$ 227.11M$ 268.67M
Total Assets$ 444.76M$ 478.52M$ 341.37M$ 292.96M$ 320.66M
Total Debt$ 207.56M$ 206.74M$ 205.92M$ 205.07M$ 204.22M
Net Debt$ -154.87M$ -197.13M$ -65.94M$ -22.05M$ -64.45M
Total Liabilities$ 258.33M$ 253.60M$ 252.70M$ 246.24M$ 240.18M
Stockholders Equity$ 186.43M$ 224.93M$ 88.67M$ 46.72M$ 80.46M
Cash Flow-
Free Cash Flow$ -45.12M$ -31.60M$ -56.25M$ -44.05M$ -66.76M
Operating Cash Flow$ -45.12M$ -31.60M$ -56.24M$ -43.98M$ -66.48M
Investing Cash Flow$ -62.14M$ -28.70M$ -62.19M$ 45.55M$ 89.12M
Financing Cash Flow$ 1.46M$ 161.76M$ 99.29M$ 867.00K$ 1.07M
Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History

Arcutis Biotherapeutics Debt to Assets

Arcutis Biotherapeutics Cash Flow

Arcutis Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis